DIN 02519879 — CAPECITABINE 150 MG
CAPECITABINE is a tablet of Capecitabine marketed by JAMP PHARMA CORPORATION. The full Capecitabine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02519879
- Brand name
- CAPECITABINE
- Active ingredient
- Capecitabine
- Strength
- 150 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- JAMP PHARMA CORPORATION
- Health Canada status
- MARKETED
- Drug class
- Antineoplastic agent - fluoropyrimidine carbamate (prodrug of 5-fluorouracil)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Capecitabine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02426757 | ACH-CAPECITABINE | 150 MG | TABLET | ACCORD HEALTHCARE INC | MARKETED |
| 02426765 | ACH-CAPECITABINE | 500 MG | TABLET | ACCORD HEALTHCARE INC | MARKETED |
| 02514982 | CAPECITABINE | 150 MG | TABLET | SANIS HEALTH INC | MARKETED |
| 02514990 | CAPECITABINE | 500 MG | TABLET | SANIS HEALTH INC | MARKETED |
| 02519887 | CAPECITABINE | 500 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02508028 | MINT-CAPECITABINE | 500 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED |
| 02421917 | SANDOZ CAPECITABINE | 150 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 02421925 | SANDOZ CAPECITABINE | 500 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 02457490 | TARO-CAPECITABINE | 150 MG | TABLET | TARO PHARMACEUTICALS INC | MARKETED |
| 02457504 | TARO-CAPECITABINE | 500 MG | TABLET | TARO PHARMACEUTICALS INC | MARKETED |